Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Correspondent™ provides on-site daily coverage of key sessions at particular scientific meetings. Conference Correspondent™ takes healthcare providers to meetings they cannot attend live, and your sponsorship helps create awareness for your brand or therapeutic area.
View All Conference Highlights
ESMO 2023 - Small Cell Lung Cancer
DLL3-Targeting T-Cell Engager HPN328 Shows Clinical Activity in SCLC and NEN
ESMO 2023 - Small Cell Lung Cancer
– October 26, 2023
European Society for Medical Oncology (ESMO)
Induction Therapy With PD-L1 Inhibitor TQB2450 + Chemotherapy Followed by Surgery or Radiotherapy in Limited-Stage SCLC
ESMO 2023 - Small Cell Lung Cancer
– October 26, 2023
European Society for Medical Oncology (ESMO)
VIEW FULL COVERAGE
ASCO 2023 - Breast Cancer
Anti-HER2/HER3 αDC1 Vaccines Plus Pembrolizumab for Brain Metastasis in Triple-Negative or HER2-Positive BC
ASCO 2023 - Breast Cancer
– June 7, 2023
American Society of Clinical Oncology (ASCO)
Neoadjuvant Intratumoral Dendritic Cell Vaccine Therapy Plus Paclitaxel, Trastuzumab, and Pertuzumab in HER2-Positive BC
ASCO 2023 - Breast Cancer
– June 7, 2023
American Society of Clinical Oncology (ASCO)
VIEW FULL COVERAGE
ONS 2023 - Multiple Myeloma: Wrap-Up
Emerging Treatment Landscape for Multiple Myeloma
ONS 2023 - Multiple Myeloma: Wrap-Up
– May 9, 2023
Oncology Nursing Society (ONS)
Nursing Considerations for Select Multiple Myeloma Treatments
ONS 2023 - Multiple Myeloma: Wrap-Up
– May 9, 2023
Oncology Nursing Society (ONS)
VIEW FULL COVERAGE
LBCL 2022 Year in Review
OUTREACH Primary Analysis and Patient-Reported Outcomes
LBCL 2022 - Year in Review
– April 27, 2023
LBCL 2022 - Year in Review
OUTREACH Study Found Outpatient Monitoring for Liso-cel to Be Feasible
LBCL 2022 - Year in Review
– April 27, 2023
LBCL 2022 - Year in Review
VIEW FULL COVERAGE
SABCS 2022
Analysis of the Randomized STIC CTC Trial in ER-Positive/HER2-Negative Metastatic Breast Cancer: Overall Survival Findings
SABCS 2022
– December 13, 2022
San Antonio Breast Cancer Symposium (SABCS)
Elacestrant in Postmenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer: Findings from the SOLTI-1905-ELIPSE Trial
SABCS 2022
– December 13, 2022
San Antonio Breast Cancer Symposium (SABCS)
VIEW FULL COVERAGE
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us